Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin M Tomera

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Expert Review of Molecular Diagnostics|November 5, 2004
NMP22 BladderChek Test: point-of-care technology with life- and money-saving potentialKevin M Tomera
Alaska Medicine|February 8, 2006
Hounsfield unit density accurately predicts ESWL successWilliam J Magnuson, Kevin M Tomera, Raymond S Lance
Antimicrobial Agents and Chemotherapy|August 17, 2002
Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter studyKevin M Tomera, Emmanuel A Burdmann, Oscar G Pamo Reyna, et al.
Frontiers in Pharmacology|April 9, 2021
COVID-19: Famotidine, Histamine, Mast Cells, and MechanismsRobert W Malone, Philip Tisdall, Philip Fremont-Smith, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Expert Review of Molecular Diagnostics|November 5, 2004
NMP22 BladderChek Test: point-of-care technology with life- and money-saving potentialKevin M Tomera
Alaska Medicine|February 8, 2006
Hounsfield unit density accurately predicts ESWL successWilliam J Magnuson, Kevin M Tomera, Raymond S Lance
Antimicrobial Agents and Chemotherapy|August 17, 2002
Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter studyKevin M Tomera, Emmanuel A Burdmann, Oscar G Pamo Reyna, et al.
Frontiers in Pharmacology|April 9, 2021
COVID-19: Famotidine, Histamine, Mast Cells, and MechanismsRobert W Malone, Philip Tisdall, Philip Fremont-Smith, et al.
Pageof 1